# AstraZeneca appoints Dr Euan Ashley as a Non-Executive Director

- Link: https://www.directorstalkinterviews.com/astrazeneca-appoints-dr-euan-ashley-as-a-non-executive-director/412860296
- Published: 2020-09-25T07:21:06+01:00
- Author: Amilia Stone

**[AstraZeneca PLC](https://www.directorstalkinterviews.com/ftse-company/astrazeneca/azn.l)**(
[LON:AZN](https://www.directorstalkinterviews.com/ftse-company/astrazeneca/azn.l))
has announced that with effect from 1 October 2020, Dr Euan Ashley is appointed 
as a Non-Executive Director and a member of the Science Committee.

Euan Ashley is Associate Dean and Professor of Cardiovascular Medicine and Genetics
at Stanford University in California.  Dr Ashley’s research focuses on genetic mechanisms
of cardiovascular health and disease.  In addition to wet bench science, his laboratory
leverages artificial intelligence and digital health tools, working with biotechnology
and technology partners in Silicon Valley, to advance both translational and clinical
research.

Dr Ashley studied physiology and medicine at Glasgow University, completing his 
junior doctor training at Oxford University Hospitals NHS Trust, before undertaking
a DPhil in cardiovascular cellular biology and molecular genetics at the University
of Oxford.  In 2002, he moved to Stanford University to train in cardiology and 
advanced heart failure.

Dr Ashley has received many awards including recognition from the Obama White House
for contributions to personalized medicine and the American Heart Association’s 
Medal of Honor for precision medicine.

> **Leif Johansson, Chairman of AstraZeneca, said: **“We look forward to welcoming
> Euan to AstraZeneca and believe his scientific achievements and interests, which
> are well-aligned with our own BioPharmaceuticals R&D, together with his entrepreneurial
> experience on the US west coast will enable him to make a significant contribution
> to the Board’s work.”

Share on:
